CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion Article Swipe
YOU?
·
· 2015
· Open Access
·
· DOI: https://doi.org/10.18632/oncotarget.4896
Glioblastoma, one of the most aggressive forms of brain cancer, is featured by high tumor cell motility and invasiveness, which not only fuel tumor infiltration, but also enable escape from surgical or other clinical interventions. Thus, better understanding of how these malignant traits are controlled will be key to the discovery of novel biomarkers and therapies against this deadly disease. Tetraspanin CD151 and its associated α3β1 integrin have been implicated in facilitating tumor progression across multiple cancer types. How these adhesion molecules are involved in the progression of glioblastoma, however, remains largely unclear. Here, we examined an in-house tissue microarray-based cohort of 96 patient biopsies and TCGA dataset to evaluate the clinical significance of CD151 and α3β1 integrin. Functional and signaling analyses were also conducted to understand how these molecules promote the aggressiveness of glioblastoma at molecular and cellular levels. Results from our analyses showed that CD151 and α3 integrin were significantly elevated in glioblastomas at both protein and mRNA levels, and exhibited strong inverse correlation with patient survival (p < 0.006). These adhesion molecules also formed tight protein complexes and synergized with EGF/EGFR to accelerate tumor cell motility and invasion. Furthermore, disruption of such complexes enhanced the survival of tumor-bearing mice in a xenograft model, and impaired activation of FAK and small GTPases. Also, knockdown- or pharmacological agent-based attenuation of EGFR, FAK or Graf (ARHGAP26)/small GTPase-mediated pathways markedly mitigated the aggressiveness of glioblastoma cells. Collectively, our findings provide clinical, molecular and cellular evidence of CD151-α3β1 integrin complexes as promising prognostic biomarkers and therapeutic targets for glioblastoma.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.18632/oncotarget.4896
- https://www.oncotarget.com/article/4896/pdf/
- OA Status
- diamond
- Cited By
- 80
- References
- 57
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W1841468843
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W1841468843Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.18632/oncotarget.4896Digital Object Identifier
- Title
-
CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasionWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2015Year of publication
- Publication date
-
2015-08-13Full publication date if available
- Authors
-
Pengcheng Zhou, Sonia Erfani, Zeyi Liu, Changhe Jia, Yecang Chen, Bingwei Xu, Xinyu Deng, Jose Alfaro, Li Chen, Dana Napier, Michael L. Lu, Jian‐An Huang, Chunming Liu, Olivier Thibault, Rosalind A. Segal, Binhua P. Zhou, Natasha Kyprianou, Craig Horbinski, Xiuwei H. YangList of authors in order
- Landing page
-
https://doi.org/10.18632/oncotarget.4896Publisher landing page
- PDF URL
-
https://www.oncotarget.com/article/4896/pdf/Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://www.oncotarget.com/article/4896/pdf/Direct OA link when available
- Concepts
-
Cancer research, Integrin, Tetraspanin, Tumor progression, Motility, Cell adhesion molecule, Biology, Focal adhesion, Gene knockdown, Cancer, Medicine, Cell, Signal transduction, Immunology, Cell biology, Cell culture, Internal medicine, GeneticsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
80Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 4, 2024: 4, 2023: 4, 2022: 10, 2021: 32Per-year citation counts (last 5 years)
- References (count)
-
57Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W1841468843 |
|---|---|
| doi | https://doi.org/10.18632/oncotarget.4896 |
| ids.doi | https://doi.org/10.18632/oncotarget.4896 |
| ids.mag | 1841468843 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/26377974 |
| ids.openalex | https://openalex.org/W1841468843 |
| fwci | 4.25019866 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000818 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Animals |
| mesh[1].qualifier_ui | Q000235 |
| mesh[1].descriptor_ui | D014408 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | genetics |
| mesh[1].descriptor_name | Biomarkers, Tumor |
| mesh[2].qualifier_ui | Q000378 |
| mesh[2].descriptor_ui | D014408 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | metabolism |
| mesh[2].descriptor_name | Biomarkers, Tumor |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D045744 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Cell Line, Tumor |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D002465 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Cell Movement |
| mesh[5].qualifier_ui | Q000235 |
| mesh[5].descriptor_ui | D049109 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | genetics |
| mesh[5].descriptor_name | Cell Proliferation |
| mesh[6].qualifier_ui | Q000378 |
| mesh[6].descriptor_ui | D066246 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | metabolism |
| mesh[6].descriptor_name | ErbB Receptors |
| mesh[7].qualifier_ui | Q000378 |
| mesh[7].descriptor_ui | D051417 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | metabolism |
| mesh[7].descriptor_name | Focal Adhesion Kinase 1 |
| mesh[8].qualifier_ui | Q000378 |
| mesh[8].descriptor_ui | D020690 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | metabolism |
| mesh[8].descriptor_name | GTPase-Activating Proteins |
| mesh[9].qualifier_ui | Q000235 |
| mesh[9].descriptor_ui | D005909 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | genetics |
| mesh[9].descriptor_name | Glioblastoma |
| mesh[10].qualifier_ui | Q000378 |
| mesh[10].descriptor_ui | D005909 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | metabolism |
| mesh[10].descriptor_name | Glioblastoma |
| mesh[11].qualifier_ui | Q000473 |
| mesh[11].descriptor_ui | D005909 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | pathology |
| mesh[11].descriptor_name | Glioblastoma |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D006801 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Humans |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D015151 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Immunoblotting |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D007150 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Immunohistochemistry |
| mesh[15].qualifier_ui | Q000235 |
| mesh[15].descriptor_ui | D039201 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | genetics |
| mesh[15].descriptor_name | Integrin alpha3beta1 |
| mesh[16].qualifier_ui | Q000378 |
| mesh[16].descriptor_ui | D039201 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | metabolism |
| mesh[16].descriptor_name | Integrin alpha3beta1 |
| mesh[17].qualifier_ui | Q000235 |
| mesh[17].descriptor_ui | D007521 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | genetics |
| mesh[17].descriptor_name | Isocitrate Dehydrogenase |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D008819 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Mice, Nude |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D009154 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Mutation |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D009361 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Neoplasm Invasiveness |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D011379 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Prognosis |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D034622 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | RNA Interference |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D016019 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Survival Analysis |
| mesh[24].qualifier_ui | Q000235 |
| mesh[24].descriptor_ui | D060185 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | genetics |
| mesh[24].descriptor_name | Tetraspanin 24 |
| mesh[25].qualifier_ui | Q000378 |
| mesh[25].descriptor_ui | D060185 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | metabolism |
| mesh[25].descriptor_name | Tetraspanin 24 |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D046888 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Tissue Array Analysis |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D014183 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Transplantation, Heterologous |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D000818 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Animals |
| mesh[29].qualifier_ui | Q000235 |
| mesh[29].descriptor_ui | D014408 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | genetics |
| mesh[29].descriptor_name | Biomarkers, Tumor |
| mesh[30].qualifier_ui | Q000378 |
| mesh[30].descriptor_ui | D014408 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | metabolism |
| mesh[30].descriptor_name | Biomarkers, Tumor |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D045744 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Cell Line, Tumor |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D002465 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Cell Movement |
| mesh[33].qualifier_ui | Q000235 |
| mesh[33].descriptor_ui | D049109 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | genetics |
| mesh[33].descriptor_name | Cell Proliferation |
| mesh[34].qualifier_ui | Q000378 |
| mesh[34].descriptor_ui | D066246 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | metabolism |
| mesh[34].descriptor_name | ErbB Receptors |
| mesh[35].qualifier_ui | Q000378 |
| mesh[35].descriptor_ui | D051417 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | metabolism |
| mesh[35].descriptor_name | Focal Adhesion Kinase 1 |
| mesh[36].qualifier_ui | Q000378 |
| mesh[36].descriptor_ui | D020690 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | metabolism |
| mesh[36].descriptor_name | GTPase-Activating Proteins |
| mesh[37].qualifier_ui | Q000235 |
| mesh[37].descriptor_ui | D005909 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | genetics |
| mesh[37].descriptor_name | Glioblastoma |
| mesh[38].qualifier_ui | Q000378 |
| mesh[38].descriptor_ui | D005909 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | metabolism |
| mesh[38].descriptor_name | Glioblastoma |
| mesh[39].qualifier_ui | Q000473 |
| mesh[39].descriptor_ui | D005909 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | pathology |
| mesh[39].descriptor_name | Glioblastoma |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D006801 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Humans |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D015151 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Immunoblotting |
| mesh[42].qualifier_ui | |
| mesh[42].descriptor_ui | D007150 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | |
| mesh[42].descriptor_name | Immunohistochemistry |
| mesh[43].qualifier_ui | Q000235 |
| mesh[43].descriptor_ui | D039201 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | genetics |
| mesh[43].descriptor_name | Integrin alpha3beta1 |
| mesh[44].qualifier_ui | Q000378 |
| mesh[44].descriptor_ui | D039201 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | metabolism |
| mesh[44].descriptor_name | Integrin alpha3beta1 |
| mesh[45].qualifier_ui | Q000235 |
| mesh[45].descriptor_ui | D007521 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | genetics |
| mesh[45].descriptor_name | Isocitrate Dehydrogenase |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D008819 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Mice, Nude |
| mesh[47].qualifier_ui | |
| mesh[47].descriptor_ui | D009154 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | |
| mesh[47].descriptor_name | Mutation |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D009361 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Neoplasm Invasiveness |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D011379 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Prognosis |
| type | article |
| title | CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion |
| biblio.issue | 30 |
| biblio.volume | 6 |
| biblio.last_page | 29693 |
| biblio.first_page | 29675 |
| topics[0].id | https://openalex.org/T10831 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2723 |
| topics[0].subfield.display_name | Immunology and Allergy |
| topics[0].display_name | Cell Adhesion Molecules Research |
| topics[1].id | https://openalex.org/T12793 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9987000226974487 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1307 |
| topics[1].subfield.display_name | Cell Biology |
| topics[1].display_name | Caveolin-1 and cellular processes |
| topics[2].id | https://openalex.org/T10379 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9959999918937683 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1307 |
| topics[2].subfield.display_name | Cell Biology |
| topics[2].display_name | Cellular Mechanics and Interactions |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C502942594 |
| concepts[0].level | 1 |
| concepts[0].score | 0.6878984570503235 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[0].display_name | Cancer research |
| concepts[1].id | https://openalex.org/C195687474 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6683804988861084 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q409715 |
| concepts[1].display_name | Integrin |
| concepts[2].id | https://openalex.org/C2777208748 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6346335411071777 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q24773957 |
| concepts[2].display_name | Tetraspanin |
| concepts[3].id | https://openalex.org/C2779256057 |
| concepts[3].level | 3 |
| concepts[3].score | 0.48853930830955505 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q16909647 |
| concepts[3].display_name | Tumor progression |
| concepts[4].id | https://openalex.org/C58207958 |
| concepts[4].level | 2 |
| concepts[4].score | 0.4634309709072113 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q33596 |
| concepts[4].display_name | Motility |
| concepts[5].id | https://openalex.org/C16224149 |
| concepts[5].level | 2 |
| concepts[5].score | 0.45775923132896423 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q187637 |
| concepts[5].display_name | Cell adhesion molecule |
| concepts[6].id | https://openalex.org/C86803240 |
| concepts[6].level | 0 |
| concepts[6].score | 0.4560326635837555 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[6].display_name | Biology |
| concepts[7].id | https://openalex.org/C151166631 |
| concepts[7].level | 3 |
| concepts[7].score | 0.4420284032821655 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q904514 |
| concepts[7].display_name | Focal adhesion |
| concepts[8].id | https://openalex.org/C173396325 |
| concepts[8].level | 3 |
| concepts[8].score | 0.4152253270149231 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1501275 |
| concepts[8].display_name | Gene knockdown |
| concepts[9].id | https://openalex.org/C121608353 |
| concepts[9].level | 2 |
| concepts[9].score | 0.4063419699668884 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[9].display_name | Cancer |
| concepts[10].id | https://openalex.org/C71924100 |
| concepts[10].level | 0 |
| concepts[10].score | 0.3609763979911804 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[10].display_name | Medicine |
| concepts[11].id | https://openalex.org/C1491633281 |
| concepts[11].level | 2 |
| concepts[11].score | 0.332908034324646 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7868 |
| concepts[11].display_name | Cell |
| concepts[12].id | https://openalex.org/C62478195 |
| concepts[12].level | 2 |
| concepts[12].score | 0.33125555515289307 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q828130 |
| concepts[12].display_name | Signal transduction |
| concepts[13].id | https://openalex.org/C203014093 |
| concepts[13].level | 1 |
| concepts[13].score | 0.21586042642593384 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[13].display_name | Immunology |
| concepts[14].id | https://openalex.org/C95444343 |
| concepts[14].level | 1 |
| concepts[14].score | 0.20763885974884033 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[14].display_name | Cell biology |
| concepts[15].id | https://openalex.org/C81885089 |
| concepts[15].level | 2 |
| concepts[15].score | 0.19102874398231506 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q189082 |
| concepts[15].display_name | Cell culture |
| concepts[16].id | https://openalex.org/C126322002 |
| concepts[16].level | 1 |
| concepts[16].score | 0.16045451164245605 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[16].display_name | Internal medicine |
| concepts[17].id | https://openalex.org/C54355233 |
| concepts[17].level | 1 |
| concepts[17].score | 0.0 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[17].display_name | Genetics |
| keywords[0].id | https://openalex.org/keywords/cancer-research |
| keywords[0].score | 0.6878984570503235 |
| keywords[0].display_name | Cancer research |
| keywords[1].id | https://openalex.org/keywords/integrin |
| keywords[1].score | 0.6683804988861084 |
| keywords[1].display_name | Integrin |
| keywords[2].id | https://openalex.org/keywords/tetraspanin |
| keywords[2].score | 0.6346335411071777 |
| keywords[2].display_name | Tetraspanin |
| keywords[3].id | https://openalex.org/keywords/tumor-progression |
| keywords[3].score | 0.48853930830955505 |
| keywords[3].display_name | Tumor progression |
| keywords[4].id | https://openalex.org/keywords/motility |
| keywords[4].score | 0.4634309709072113 |
| keywords[4].display_name | Motility |
| keywords[5].id | https://openalex.org/keywords/cell-adhesion-molecule |
| keywords[5].score | 0.45775923132896423 |
| keywords[5].display_name | Cell adhesion molecule |
| keywords[6].id | https://openalex.org/keywords/biology |
| keywords[6].score | 0.4560326635837555 |
| keywords[6].display_name | Biology |
| keywords[7].id | https://openalex.org/keywords/focal-adhesion |
| keywords[7].score | 0.4420284032821655 |
| keywords[7].display_name | Focal adhesion |
| keywords[8].id | https://openalex.org/keywords/gene-knockdown |
| keywords[8].score | 0.4152253270149231 |
| keywords[8].display_name | Gene knockdown |
| keywords[9].id | https://openalex.org/keywords/cancer |
| keywords[9].score | 0.4063419699668884 |
| keywords[9].display_name | Cancer |
| keywords[10].id | https://openalex.org/keywords/medicine |
| keywords[10].score | 0.3609763979911804 |
| keywords[10].display_name | Medicine |
| keywords[11].id | https://openalex.org/keywords/cell |
| keywords[11].score | 0.332908034324646 |
| keywords[11].display_name | Cell |
| keywords[12].id | https://openalex.org/keywords/signal-transduction |
| keywords[12].score | 0.33125555515289307 |
| keywords[12].display_name | Signal transduction |
| keywords[13].id | https://openalex.org/keywords/immunology |
| keywords[13].score | 0.21586042642593384 |
| keywords[13].display_name | Immunology |
| keywords[14].id | https://openalex.org/keywords/cell-biology |
| keywords[14].score | 0.20763885974884033 |
| keywords[14].display_name | Cell biology |
| keywords[15].id | https://openalex.org/keywords/cell-culture |
| keywords[15].score | 0.19102874398231506 |
| keywords[15].display_name | Cell culture |
| keywords[16].id | https://openalex.org/keywords/internal-medicine |
| keywords[16].score | 0.16045451164245605 |
| keywords[16].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.18632/oncotarget.4896 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S126644158 |
| locations[0].source.issn | 1949-2553 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1949-2553 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Oncotarget |
| locations[0].source.host_organization | https://openalex.org/P4310316297 |
| locations[0].source.host_organization_name | Impact Journals LLC |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310316297 |
| locations[0].source.host_organization_lineage_names | Impact Journals LLC |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.oncotarget.com/article/4896/pdf/ |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Oncotarget |
| locations[0].landing_page_url | https://doi.org/10.18632/oncotarget.4896 |
| locations[1].id | pmid:26377974 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Oncotarget |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/26377974 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:4745755 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Oncotarget |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/4745755 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5101742556 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-7030-0525 |
| authorships[0].author.display_name | Pengcheng Zhou |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I136199984 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Cancer Biology and Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. |
| authorships[0].institutions[0].id | https://openalex.org/I136199984 |
| authorships[0].institutions[0].ror | https://ror.org/03vek6s52 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I136199984 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Harvard University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Pengcheng Zhou |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Cancer Biology and Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. |
| authorships[1].author.id | https://openalex.org/A5023983448 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Sonia Erfani |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I143302722 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Pharmacology and Nutritional Sciences, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[1].institutions[0].id | https://openalex.org/I143302722 |
| authorships[1].institutions[0].ror | https://ror.org/02k3smh20 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I143302722 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | University of Kentucky |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Sonia Erfani |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Pharmacology and Nutritional Sciences, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[2].author.id | https://openalex.org/A5054656489 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-2528-6909 |
| authorships[2].author.display_name | Zeyi Liu |
| authorships[2].countries | CN, US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I3923682, https://openalex.org/I4210153519 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Respiratory Medicine, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, P. R. China |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I143302722 |
| authorships[2].affiliations[1].raw_affiliation_string | Department of Pharmacology and Nutritional Sciences, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[2].institutions[0].id | https://openalex.org/I4210153519 |
| authorships[2].institutions[0].ror | https://ror.org/051jg5p78 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210153519 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | First Affiliated Hospital of Soochow University |
| authorships[2].institutions[1].id | https://openalex.org/I3923682 |
| authorships[2].institutions[1].ror | https://ror.org/05t8y2r12 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I3923682 |
| authorships[2].institutions[1].country_code | CN |
| authorships[2].institutions[1].display_name | Soochow University |
| authorships[2].institutions[2].id | https://openalex.org/I143302722 |
| authorships[2].institutions[2].ror | https://ror.org/02k3smh20 |
| authorships[2].institutions[2].type | education |
| authorships[2].institutions[2].lineage | https://openalex.org/I143302722 |
| authorships[2].institutions[2].country_code | US |
| authorships[2].institutions[2].display_name | University of Kentucky |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Zeyi Liu |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Pharmacology and Nutritional Sciences, Markey Cancer Center and University of Kentucky, Lexington, KY, USA., Department of Respiratory Medicine, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, P. R. China |
| authorships[3].author.id | https://openalex.org/A5034156262 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-4257-565X |
| authorships[3].author.display_name | Changhe Jia |
| authorships[3].countries | CN, US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210133534 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Gastroenterology, Provincial People's Hospital, Zhengzhou, Henan Province, P. R. China |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I143302722 |
| authorships[3].affiliations[1].raw_affiliation_string | Department of Pharmacology and Nutritional Sciences, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[3].institutions[0].id | https://openalex.org/I4210133534 |
| authorships[3].institutions[0].ror | https://ror.org/03f72zw41 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210133534 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | Henan Provincial People's Hospital |
| authorships[3].institutions[1].id | https://openalex.org/I143302722 |
| authorships[3].institutions[1].ror | https://ror.org/02k3smh20 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I143302722 |
| authorships[3].institutions[1].country_code | US |
| authorships[3].institutions[1].display_name | University of Kentucky |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Changhe Jia |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Gastroenterology, Provincial People's Hospital, Zhengzhou, Henan Province, P. R. China, Department of Pharmacology and Nutritional Sciences, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[4].author.id | https://openalex.org/A5011040044 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Yecang Chen |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I143302722 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Chemistry, University of Kentucky, Lexington, KY, USA#TAB# |
| authorships[4].institutions[0].id | https://openalex.org/I143302722 |
| authorships[4].institutions[0].ror | https://ror.org/02k3smh20 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I143302722 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | University of Kentucky |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Yecang Chen |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Chemistry, University of Kentucky, Lexington, KY, USA#TAB# |
| authorships[5].author.id | https://openalex.org/A5027062741 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Bingwei Xu |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I143302722 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Pharmacology and Nutritional Sciences, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[5].institutions[0].id | https://openalex.org/I143302722 |
| authorships[5].institutions[0].ror | https://ror.org/02k3smh20 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I143302722 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | University of Kentucky |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Bingwei Xu |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Pharmacology and Nutritional Sciences, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[6].author.id | https://openalex.org/A5101467244 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-6726-644X |
| authorships[6].author.display_name | Xinyu Deng |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I143302722 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Pharmacology and Nutritional Sciences, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[6].institutions[0].id | https://openalex.org/I143302722 |
| authorships[6].institutions[0].ror | https://ror.org/02k3smh20 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I143302722 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | University of Kentucky |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Xinyu Deng |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Pharmacology and Nutritional Sciences, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[7].author.id | https://openalex.org/A5078603667 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Jose Alfaro |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I136199984 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Cancer Biology and Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. |
| authorships[7].institutions[0].id | https://openalex.org/I136199984 |
| authorships[7].institutions[0].ror | https://ror.org/03vek6s52 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I136199984 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Harvard University |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Jose E. Alfáro |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Cancer Biology and Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. |
| authorships[8].author.id | https://openalex.org/A5100379200 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-9971-9653 |
| authorships[8].author.display_name | Li Chen |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I143302722 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Pharmacology and Nutritional Sciences, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[8].institutions[0].id | https://openalex.org/I143302722 |
| authorships[8].institutions[0].ror | https://ror.org/02k3smh20 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I143302722 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | University of Kentucky |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Li Chen |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Pharmacology and Nutritional Sciences, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[9].author.id | https://openalex.org/A5021562291 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Dana Napier |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I143302722 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Pathology and Laboratory Medicine, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[9].institutions[0].id | https://openalex.org/I143302722 |
| authorships[9].institutions[0].ror | https://ror.org/02k3smh20 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I143302722 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | University of Kentucky |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Dana Napier |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Pathology and Laboratory Medicine, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[10].author.id | https://openalex.org/A5039806235 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-4659-943X |
| authorships[10].author.display_name | Michael L. Lu |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I63772739 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Biomedical Science, Florida Atlantic University, Boca Raton, FL, USA |
| authorships[10].institutions[0].id | https://openalex.org/I63772739 |
| authorships[10].institutions[0].ror | https://ror.org/05p8w6387 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I63772739 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | Florida Atlantic University |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Michael Lu |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Biomedical Science, Florida Atlantic University, Boca Raton, FL, USA |
| authorships[11].author.id | https://openalex.org/A5100678835 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Jian‐An Huang |
| authorships[11].countries | CN |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I3923682 |
| authorships[11].affiliations[0].raw_affiliation_string | Department of Respiratory Medicine, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, P. R. China. |
| authorships[11].institutions[0].id | https://openalex.org/I3923682 |
| authorships[11].institutions[0].ror | https://ror.org/05t8y2r12 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I3923682 |
| authorships[11].institutions[0].country_code | CN |
| authorships[11].institutions[0].display_name | Soochow University |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Jian-An Huang |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Department of Respiratory Medicine, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, P. R. China. |
| authorships[12].author.id | https://openalex.org/A5100623406 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-3913-4474 |
| authorships[12].author.display_name | Chunming Liu |
| authorships[12].countries | US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I143302722 |
| authorships[12].affiliations[0].raw_affiliation_string | Department of Molecular and Cellular Biochemistry, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[12].institutions[0].id | https://openalex.org/I143302722 |
| authorships[12].institutions[0].ror | https://ror.org/02k3smh20 |
| authorships[12].institutions[0].type | education |
| authorships[12].institutions[0].lineage | https://openalex.org/I143302722 |
| authorships[12].institutions[0].country_code | US |
| authorships[12].institutions[0].display_name | University of Kentucky |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Chunming Liu |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Department of Molecular and Cellular Biochemistry, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[13].author.id | https://openalex.org/A5101436772 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-3548-3466 |
| authorships[13].author.display_name | Olivier Thibault |
| authorships[13].countries | US |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I143302722 |
| authorships[13].affiliations[0].raw_affiliation_string | Department of Pharmacology and Nutritional Sciences, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[13].institutions[0].id | https://openalex.org/I143302722 |
| authorships[13].institutions[0].ror | https://ror.org/02k3smh20 |
| authorships[13].institutions[0].type | education |
| authorships[13].institutions[0].lineage | https://openalex.org/I143302722 |
| authorships[13].institutions[0].country_code | US |
| authorships[13].institutions[0].display_name | University of Kentucky |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Olivier Thibault |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Department of Pharmacology and Nutritional Sciences, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[14].author.id | https://openalex.org/A5085644511 |
| authorships[14].author.orcid | https://orcid.org/0000-0001-9850-8432 |
| authorships[14].author.display_name | Rosalind A. Segal |
| authorships[14].countries | US |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I136199984 |
| authorships[14].affiliations[0].raw_affiliation_string | Department of Cancer Biology and Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. |
| authorships[14].institutions[0].id | https://openalex.org/I136199984 |
| authorships[14].institutions[0].ror | https://ror.org/03vek6s52 |
| authorships[14].institutions[0].type | education |
| authorships[14].institutions[0].lineage | https://openalex.org/I136199984 |
| authorships[14].institutions[0].country_code | US |
| authorships[14].institutions[0].display_name | Harvard University |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Rosalind Segal |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Department of Cancer Biology and Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. |
| authorships[15].author.id | https://openalex.org/A5008517264 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-6136-6749 |
| authorships[15].author.display_name | Binhua P. Zhou |
| authorships[15].countries | US |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I143302722 |
| authorships[15].affiliations[0].raw_affiliation_string | Department of Molecular and Cellular Biochemistry, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[15].institutions[0].id | https://openalex.org/I143302722 |
| authorships[15].institutions[0].ror | https://ror.org/02k3smh20 |
| authorships[15].institutions[0].type | education |
| authorships[15].institutions[0].lineage | https://openalex.org/I143302722 |
| authorships[15].institutions[0].country_code | US |
| authorships[15].institutions[0].display_name | University of Kentucky |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Binhua P. Zhou |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Department of Molecular and Cellular Biochemistry, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[16].author.id | https://openalex.org/A5102885741 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-9382-9664 |
| authorships[16].author.display_name | Natasha Kyprianou |
| authorships[16].countries | US |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I143302722 |
| authorships[16].affiliations[0].raw_affiliation_string | Department of Urology, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[16].institutions[0].id | https://openalex.org/I143302722 |
| authorships[16].institutions[0].ror | https://ror.org/02k3smh20 |
| authorships[16].institutions[0].type | education |
| authorships[16].institutions[0].lineage | https://openalex.org/I143302722 |
| authorships[16].institutions[0].country_code | US |
| authorships[16].institutions[0].display_name | University of Kentucky |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Natasha Kyprianou |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Department of Urology, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[17].author.id | https://openalex.org/A5009670051 |
| authorships[17].author.orcid | https://orcid.org/0000-0001-8340-9992 |
| authorships[17].author.display_name | Craig Horbinski |
| authorships[17].countries | US |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I143302722 |
| authorships[17].affiliations[0].raw_affiliation_string | Department of Pathology and Laboratory Medicine, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[17].institutions[0].id | https://openalex.org/I143302722 |
| authorships[17].institutions[0].ror | https://ror.org/02k3smh20 |
| authorships[17].institutions[0].type | education |
| authorships[17].institutions[0].lineage | https://openalex.org/I143302722 |
| authorships[17].institutions[0].country_code | US |
| authorships[17].institutions[0].display_name | University of Kentucky |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Craig Horbinski |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Department of Pathology and Laboratory Medicine, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[18].author.id | https://openalex.org/A5043356539 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-5591-6951 |
| authorships[18].author.display_name | Xiuwei H. Yang |
| authorships[18].countries | US |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I143302722 |
| authorships[18].affiliations[0].raw_affiliation_string | Department of Pharmacology and Nutritional Sciences, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| authorships[18].institutions[0].id | https://openalex.org/I143302722 |
| authorships[18].institutions[0].ror | https://ror.org/02k3smh20 |
| authorships[18].institutions[0].type | education |
| authorships[18].institutions[0].lineage | https://openalex.org/I143302722 |
| authorships[18].institutions[0].country_code | US |
| authorships[18].institutions[0].display_name | University of Kentucky |
| authorships[18].author_position | last |
| authorships[18].raw_author_name | Xiuwei H. Yang |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Department of Pharmacology and Nutritional Sciences, Markey Cancer Center and University of Kentucky, Lexington, KY, USA. |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.oncotarget.com/article/4896/pdf/ |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10831 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2723 |
| primary_topic.subfield.display_name | Immunology and Allergy |
| primary_topic.display_name | Cell Adhesion Molecules Research |
| related_works | https://openalex.org/W2118969537, https://openalex.org/W2119767687, https://openalex.org/W1924064381, https://openalex.org/W2163524438, https://openalex.org/W2107151297, https://openalex.org/W2064977142, https://openalex.org/W1543594980, https://openalex.org/W2011227811, https://openalex.org/W2143563593, https://openalex.org/W2517195827 |
| cited_by_count | 80 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 4 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 4 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 4 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 10 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 32 |
| counts_by_year[5].year | 2020 |
| counts_by_year[5].cited_by_count | 4 |
| counts_by_year[6].year | 2019 |
| counts_by_year[6].cited_by_count | 2 |
| counts_by_year[7].year | 2018 |
| counts_by_year[7].cited_by_count | 6 |
| counts_by_year[8].year | 2017 |
| counts_by_year[8].cited_by_count | 7 |
| counts_by_year[9].year | 2016 |
| counts_by_year[9].cited_by_count | 6 |
| counts_by_year[10].year | 2015 |
| counts_by_year[10].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.18632/oncotarget.4896 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S126644158 |
| best_oa_location.source.issn | 1949-2553 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1949-2553 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Oncotarget |
| best_oa_location.source.host_organization | https://openalex.org/P4310316297 |
| best_oa_location.source.host_organization_name | Impact Journals LLC |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310316297 |
| best_oa_location.source.host_organization_lineage_names | Impact Journals LLC |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.oncotarget.com/article/4896/pdf/ |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Oncotarget |
| best_oa_location.landing_page_url | https://doi.org/10.18632/oncotarget.4896 |
| primary_location.id | doi:10.18632/oncotarget.4896 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S126644158 |
| primary_location.source.issn | 1949-2553 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1949-2553 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Oncotarget |
| primary_location.source.host_organization | https://openalex.org/P4310316297 |
| primary_location.source.host_organization_name | Impact Journals LLC |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310316297 |
| primary_location.source.host_organization_lineage_names | Impact Journals LLC |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.oncotarget.com/article/4896/pdf/ |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Oncotarget |
| primary_location.landing_page_url | https://doi.org/10.18632/oncotarget.4896 |
| publication_date | 2015-08-13 |
| publication_year | 2015 |
| referenced_works | https://openalex.org/W2142188858, https://openalex.org/W2060147931, https://openalex.org/W2166798417, https://openalex.org/W2163676912, https://openalex.org/W2018784116, https://openalex.org/W1576773659, https://openalex.org/W2039553196, https://openalex.org/W2070292028, https://openalex.org/W2030083747, https://openalex.org/W2004471993, https://openalex.org/W2115899432, https://openalex.org/W6678153812, https://openalex.org/W2161287613, https://openalex.org/W2114294642, https://openalex.org/W1967427925, https://openalex.org/W1900346306, https://openalex.org/W2096477148, https://openalex.org/W2063186096, https://openalex.org/W2143563593, https://openalex.org/W2055232509, https://openalex.org/W2012129117, https://openalex.org/W2118832127, https://openalex.org/W1969096316, https://openalex.org/W2169301285, https://openalex.org/W1529076521, https://openalex.org/W1975625841, https://openalex.org/W2159817656, https://openalex.org/W2102040455, https://openalex.org/W2132543766, https://openalex.org/W2124393085, https://openalex.org/W2019226300, https://openalex.org/W2103940139, https://openalex.org/W2159976463, https://openalex.org/W2107203636, https://openalex.org/W2039892426, https://openalex.org/W2054210950, https://openalex.org/W2114551767, https://openalex.org/W1978232668, https://openalex.org/W1999576341, https://openalex.org/W2119892498, https://openalex.org/W3190496831, https://openalex.org/W1971759686, https://openalex.org/W2125182848, https://openalex.org/W1980576384, https://openalex.org/W1577573926, https://openalex.org/W1994683314, https://openalex.org/W2009707750, https://openalex.org/W2079278662, https://openalex.org/W2118769864, https://openalex.org/W2037173620, https://openalex.org/W2160235573, https://openalex.org/W2129485273, https://openalex.org/W2018180485, https://openalex.org/W2100825620, https://openalex.org/W2056918364, https://openalex.org/W2124981584, https://openalex.org/W2118969537 |
| referenced_works_count | 57 |
| abstract_inverted_index.< | 170 |
| abstract_inverted_index.a | 203 |
| abstract_inverted_index.(p | 169 |
| abstract_inverted_index.96 | 102 |
| abstract_inverted_index.an | 96 |
| abstract_inverted_index.as | 248 |
| abstract_inverted_index.at | 135, 155 |
| abstract_inverted_index.be | 46 |
| abstract_inverted_index.by | 12 |
| abstract_inverted_index.in | 70, 84, 153, 202 |
| abstract_inverted_index.is | 10 |
| abstract_inverted_index.of | 2, 7, 38, 51, 87, 101, 113, 133, 193, 199, 209, 220, 232, 244 |
| abstract_inverted_index.or | 31, 216, 223 |
| abstract_inverted_index.to | 48, 108, 125, 184 |
| abstract_inverted_index.we | 94 |
| abstract_inverted_index.FAK | 210, 222 |
| abstract_inverted_index.How | 78 |
| abstract_inverted_index.and | 17, 54, 62, 105, 115, 119, 137, 147, 158, 161, 180, 189, 206, 211, 241, 252 |
| abstract_inverted_index.are | 43, 82 |
| abstract_inverted_index.but | 25 |
| abstract_inverted_index.for | 255 |
| abstract_inverted_index.how | 39, 127 |
| abstract_inverted_index.its | 63 |
| abstract_inverted_index.key | 47 |
| abstract_inverted_index.not | 20 |
| abstract_inverted_index.one | 1 |
| abstract_inverted_index.our | 142, 236 |
| abstract_inverted_index.the | 3, 49, 85, 110, 131, 197, 230 |
| abstract_inverted_index.α3 | 148 |
| abstract_inverted_index.Graf | 224 |
| abstract_inverted_index.TCGA | 106 |
| abstract_inverted_index.also | 26, 123, 175 |
| abstract_inverted_index.been | 68 |
| abstract_inverted_index.both | 156 |
| abstract_inverted_index.cell | 15, 187 |
| abstract_inverted_index.from | 29, 141 |
| abstract_inverted_index.fuel | 22 |
| abstract_inverted_index.have | 67 |
| abstract_inverted_index.high | 13 |
| abstract_inverted_index.mRNA | 159 |
| abstract_inverted_index.mice | 201 |
| abstract_inverted_index.most | 4 |
| abstract_inverted_index.only | 21 |
| abstract_inverted_index.such | 194 |
| abstract_inverted_index.that | 145 |
| abstract_inverted_index.this | 57 |
| abstract_inverted_index.were | 122, 150 |
| abstract_inverted_index.will | 45 |
| abstract_inverted_index.with | 166, 182 |
| abstract_inverted_index.Also, | 214 |
| abstract_inverted_index.CD151 | 61, 114, 146 |
| abstract_inverted_index.EGFR, | 221 |
| abstract_inverted_index.Here, | 93 |
| abstract_inverted_index.These | 172 |
| abstract_inverted_index.Thus, | 35 |
| abstract_inverted_index.brain | 8 |
| abstract_inverted_index.forms | 6 |
| abstract_inverted_index.novel | 52 |
| abstract_inverted_index.other | 32 |
| abstract_inverted_index.small | 212 |
| abstract_inverted_index.these | 40, 79, 128 |
| abstract_inverted_index.tight | 177 |
| abstract_inverted_index.tumor | 14, 23, 72, 186 |
| abstract_inverted_index.which | 19 |
| abstract_inverted_index.across | 74 |
| abstract_inverted_index.better | 36 |
| abstract_inverted_index.cancer | 76 |
| abstract_inverted_index.cells. | 234 |
| abstract_inverted_index.cohort | 100 |
| abstract_inverted_index.deadly | 58 |
| abstract_inverted_index.enable | 27 |
| abstract_inverted_index.escape | 28 |
| abstract_inverted_index.formed | 176 |
| abstract_inverted_index.model, | 205 |
| abstract_inverted_index.showed | 144 |
| abstract_inverted_index.strong | 163 |
| abstract_inverted_index.tissue | 98 |
| abstract_inverted_index.traits | 42 |
| abstract_inverted_index.types. | 77 |
| abstract_inverted_index.α3β1 | 65, 116 |
| abstract_inverted_index.0.006). | 171 |
| abstract_inverted_index.Results | 140 |
| abstract_inverted_index.against | 56 |
| abstract_inverted_index.cancer, | 9 |
| abstract_inverted_index.dataset | 107 |
| abstract_inverted_index.inverse | 164 |
| abstract_inverted_index.largely | 91 |
| abstract_inverted_index.levels, | 160 |
| abstract_inverted_index.levels. | 139 |
| abstract_inverted_index.patient | 103, 167 |
| abstract_inverted_index.promote | 130 |
| abstract_inverted_index.protein | 157, 178 |
| abstract_inverted_index.provide | 238 |
| abstract_inverted_index.remains | 90 |
| abstract_inverted_index.targets | 254 |
| abstract_inverted_index.EGF/EGFR | 183 |
| abstract_inverted_index.GTPases. | 213 |
| abstract_inverted_index.adhesion | 80, 173 |
| abstract_inverted_index.analyses | 121, 143 |
| abstract_inverted_index.biopsies | 104 |
| abstract_inverted_index.cellular | 138, 242 |
| abstract_inverted_index.clinical | 33, 111 |
| abstract_inverted_index.disease. | 59 |
| abstract_inverted_index.elevated | 152 |
| abstract_inverted_index.enhanced | 196 |
| abstract_inverted_index.evaluate | 109 |
| abstract_inverted_index.evidence | 243 |
| abstract_inverted_index.examined | 95 |
| abstract_inverted_index.featured | 11 |
| abstract_inverted_index.findings | 237 |
| abstract_inverted_index.however, | 89 |
| abstract_inverted_index.impaired | 207 |
| abstract_inverted_index.in-house | 97 |
| abstract_inverted_index.integrin | 66, 149, 246 |
| abstract_inverted_index.involved | 83 |
| abstract_inverted_index.markedly | 228 |
| abstract_inverted_index.motility | 16, 188 |
| abstract_inverted_index.multiple | 75 |
| abstract_inverted_index.pathways | 227 |
| abstract_inverted_index.surgical | 30 |
| abstract_inverted_index.survival | 168, 198 |
| abstract_inverted_index.unclear. | 92 |
| abstract_inverted_index.clinical, | 239 |
| abstract_inverted_index.complexes | 179, 195, 247 |
| abstract_inverted_index.conducted | 124 |
| abstract_inverted_index.discovery | 50 |
| abstract_inverted_index.exhibited | 162 |
| abstract_inverted_index.integrin. | 117 |
| abstract_inverted_index.invasion. | 190 |
| abstract_inverted_index.malignant | 41 |
| abstract_inverted_index.mitigated | 229 |
| abstract_inverted_index.molecular | 136, 240 |
| abstract_inverted_index.molecules | 81, 129, 174 |
| abstract_inverted_index.promising | 249 |
| abstract_inverted_index.signaling | 120 |
| abstract_inverted_index.therapies | 55 |
| abstract_inverted_index.xenograft | 204 |
| abstract_inverted_index.Functional | 118 |
| abstract_inverted_index.accelerate | 185 |
| abstract_inverted_index.activation | 208 |
| abstract_inverted_index.aggressive | 5 |
| abstract_inverted_index.associated | 64 |
| abstract_inverted_index.biomarkers | 53, 251 |
| abstract_inverted_index.controlled | 44 |
| abstract_inverted_index.disruption | 192 |
| abstract_inverted_index.implicated | 69 |
| abstract_inverted_index.knockdown- | 215 |
| abstract_inverted_index.prognostic | 250 |
| abstract_inverted_index.synergized | 181 |
| abstract_inverted_index.understand | 126 |
| abstract_inverted_index.Tetraspanin | 60 |
| abstract_inverted_index.agent-based | 218 |
| abstract_inverted_index.attenuation | 219 |
| abstract_inverted_index.correlation | 165 |
| abstract_inverted_index.progression | 73, 86 |
| abstract_inverted_index.therapeutic | 253 |
| abstract_inverted_index.CD151-α3β1 | 245 |
| abstract_inverted_index.Furthermore, | 191 |
| abstract_inverted_index.facilitating | 71 |
| abstract_inverted_index.glioblastoma | 134, 233 |
| abstract_inverted_index.significance | 112 |
| abstract_inverted_index.Collectively, | 235 |
| abstract_inverted_index.Glioblastoma, | 0 |
| abstract_inverted_index.glioblastoma, | 88 |
| abstract_inverted_index.glioblastoma. | 256 |
| abstract_inverted_index.glioblastomas | 154 |
| abstract_inverted_index.infiltration, | 24 |
| abstract_inverted_index.invasiveness, | 18 |
| abstract_inverted_index.significantly | 151 |
| abstract_inverted_index.tumor-bearing | 200 |
| abstract_inverted_index.understanding | 37 |
| abstract_inverted_index.aggressiveness | 132, 231 |
| abstract_inverted_index.interventions. | 34 |
| abstract_inverted_index.GTPase-mediated | 226 |
| abstract_inverted_index.pharmacological | 217 |
| abstract_inverted_index.(ARHGAP26)/small | 225 |
| abstract_inverted_index.microarray-based | 99 |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 19 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/2 |
| sustainable_development_goals[0].score | 0.5600000023841858 |
| sustainable_development_goals[0].display_name | Zero hunger |
| citation_normalized_percentile.value | 0.93849564 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |